Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Schizophr Res. 2013 Mar 1;146(0):184–189. doi: 10.1016/j.schres.2013.02.001

Figure 1.

Figure 1

(A) The reduced form of glutathione (GSH) in schizophrenia patients (red bar) was significantly lower compared with controls (black bar) (* p<0.001). (B) Percent of the oxidized form of glutathione (GSSG) was significantly increased in schizophrenia patients compared with controls (* p=0.023). Note the large variance in the patient group, due to %GSSG over 50% in 3 patients. (C) However, even after removing the 3 patients with extremely high %GSSG, patients were still significant different from controls in %GSSG (* p=0.027).